ロード中...
Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia
Dysbiosis of the gut microbiota is a contributing factor for obesity-related metabolic diseases such as hyperglycemia and hyperlipidemia. Pharmacotherapy for metabolic diseases involves the modulation of gut microbiota, which is suggested to be a potential therapeutic target. In this study, the modu...
保存先:
| 出版年: | Front Microbiol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736992/ https://ncbi.nlm.nih.gov/pubmed/31551944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2019.01947 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|